Literature DB >> 19901914

Intravesical oxybutynin in the pediatric neurogenic bladder.

John Lazarus1.   

Abstract

Pediatric neuropathic bladder dysfunction can cause irreversible renal damage and urinary incontinence. Etiologically, it is usually the consequence of a congenital neural tube defect. The majority of affected children can be successfully managed with the standard medical treatment of clean intermittent catheterization and anticholinergic (typically oxybutynin) medication. A subset of patients experience severe side effects or insufficient suppression of detrusor overactivity on oral oxybutynin. Intravesical instillations offer an effective alternative; this Review considers their indications, administration, safety and efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901914     DOI: 10.1038/nrurol.2009.214

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  22 in total

Review 1.  Muscarinic receptor subtypes and management of the overactive bladder.

Authors:  Christopher R Chapple; Tomonori Yamanishi; Russell Chess-Williams
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

2.  Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity.

Authors:  Hamilto Yamamoto; Paulo Roberto Kawano; Karina Tuma Balasteghin; Carlos Roberto Padovani; João Luiz Amaro
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-25

3.  Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.

Authors:  Israel Franco; Mark Horowitz; Richard Grady; Richard C Adams; Tom P V M de Jong; Kelly Lindert; Detlef Albrecht
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

4.  Early start to therapy preserves kidney function in spina bifida patients.

Authors:  Pieter Dik; Aart J Klijn; Jan D van Gool; Catherine C E de Jong-de Vos van Steenwijk; Tom P V M de Jong
Journal:  Eur Urol       Date:  2006-01-19       Impact factor: 20.096

5.  Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.

Authors:  Mandy Fader; Scott Glickman; Veronica Haggar; Rachel Barton; Rodney Brooks; James Malone-Lee
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

6.  Topical oxybutynin chloride for relaxation of dysfunctional bladders.

Authors:  C B Brendler; L C Radebaugh; J L Mohler
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

7.  The durability of intravesical oxybutynin solutions over time.

Authors:  Julian Wan; Cody Rickman
Journal:  J Urol       Date:  2007-08-17       Impact factor: 7.450

8.  Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children.

Authors:  Atsushi Hayashi; Motoaki Saito; Shin-ichi Okada; Takuya Hanada; Takeshi Watanabe; Keisuke Satoh; Susumu Kanzaki
Journal:  J Pediatr Urol       Date:  2007-08-02       Impact factor: 1.830

9.  Intravesical vanilloids and neurogenic incontinence: ten years experience.

Authors:  Massimo Lazzeri; Michele Spinelli; Alberto Zanollo; Damiano Turini
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

10.  Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.

Authors:  Khalid Fouda Neel; Mahmoud Salem; Sherif Soliman
Journal:  J Pediatr Urol       Date:  2008-01-02       Impact factor: 1.830

View more
  3 in total

1.  Long-Term Efficacy, Safety, and Tolerability of Modified Intravesical Oxybutynin Chloride for Neurogenic Bladder in Children.

Authors:  Masashi Honda; Yusuke Kimura; Panagiota Tsounapi; Katsuya Hikita; Motoaki Saito; Atsushi Takenaka
Journal:  J Clin Med Res       Date:  2019-03-18

Review 2.  Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases.

Authors:  Justin Loloi; Mustufa Babar; Kelvin P Davies; Sylvia O Suadicani
Journal:  Ther Adv Urol       Date:  2022-07-26

Review 3.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.